v3 Template
R

Royalty Pharma plc

Biopharmaceuticals / Life Sciences New York, USA ~500 employees
Founded
--
Employees (Est.)
~500
25 leaders known
Total Funding
$4.0B
Funding Rounds
3
Last Funding
2025-09-02

About Royalty Pharma plc

Royalty Pharma is the world's largest buyer of biopharmaceutical royalties and a leading funder of innovation in the life sciences. Operating at the intersection of science, medicine, and investing, they provide tailored funding solutions and create win-win partnerships within the biopharma ecosystem, holding over 60% of the global market share in this space.

Products & Services

Biopharmaceutical Royalties:Royalty Pharma acquires existing and synthetic royalties on biopharmaceutical products, providing capital to partners.
Funding Solutions:Offers various funding solutions including launch and development capital, and facilitates M&A in the life sciences sector.
Partnerships:Collaborates with biotechnology companies, global pharmaceuticals, academic institutions, and non-profits to fund innovation.

Specialties

Biopharmaceutical Royalties Funding Innovation in Life Sciences Tailored Funding Solutions Partnerships in Biotechnology and Pharmaceuticals

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Debt
T: -
FT: Debt
A: 2000000000
MR: -
FA: 2.0 billion
FAN: 2000000000
D: 2025-09-02
FD: 2025-09-02
19 investors
2 RT: Debt
T: -
FT: Debt
A: 530000000
MR: -
FA: $530 million
FAN: 530000000
D: 2025-01-29
FD: 2025-01-29
1 investors
3 RT: Debt
T: -
FT: Debt
A: 1500000000
MR: -
FA: 1.5 billion
FAN: 1500000000
D: 2024-06-03
FD: 2024-06-03
18 investors
Debt Latest
2025-09-02
$2.0B
19 investors (Pro only)
Debt 2025-01-29
$530.0M
Debt 2024-06-03
$1.5B

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

P

Pablo Legorreta

Founder & Chief Executive Officer

B

Bonnie Bassler, PhD

Member of the Board of Directors

V

Vlad Coric, MD

Chief Executive Officer

E

Errol De Souza, PhD

Former Executive Chairman

C

Cathy Engelbert

Commissioner of the Women’s National Basketball Association (WNBA)

H

Henry A. Fernandez

Director and Chairman of MSCI Inc., Chief Executive Officer

View 22 more team members with Pro

Unlock Full Team Directory

Recent News

Royalty Pharma plc Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biopharmaceuticals / Life Sciences
Company Size
~500 employees (est.)
Locations
New York, USA
New York
New York City

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro